Recent Press Releases
Oct 29, 2009 Oct 23, 2009Allergan Announces Victory in Brimonidine Patent Infringement Case
Oct 1, 2009Allergan Files Federal Lawsuit to Allow It to Share Relevant Information with the Medical Community on the Safe Use of BOTOX(R) for Common Therapeutic Off-Label Treatments
Sep 30, 2009 Sep 25, 2009Quintiles and Allergan Announce Co-Promotion for Sanctura XR(R)
Jul 31, 2009 Jul 23, 2009Allergan Receives FDA Approval for ACUVAIL(TM) Ophthalmic Solution for the Treatment of Pain and Inflammation Following Cataract Surgery
Jul 21, 2009FDA Designates Fast Track Status for Apaziquone (EOquin(R)) for Bladder Cancer
Jul 6, 2009 Jun 18, 2009Allergan Receives FDA Approval for OZURDEX™ Biodegradable, Injectable Steroid Implant with Extended Drug Release for Retinal Disease
May 26, 2009Allergan Receives Complete Response Letter for BOTOX(R) (Botulinum Toxin Type A) for Treatment of Upper Limb Spasticity in Adults
May 15, 2009VIDEO: Allergan, Inc. Announces the 'BOTOX(R) Cosmetic: Express Success' Charitable Education Campaign, Committing $250,000 to the Not-For-Profit Dress for Success
May 1, 2009 Apr 30, 2009Allergan Comments on Today's Follow up by the U.S. Food and Drug Administration (FDA) to Its Early Communication, Concluding the Agency's Safety Review of Botulinum Toxins
Apr 30, 2009Allergan Comments on FDA Requested Class Labeling for Botulinum Toxin Treatments in Connection with Approval of DYSPORT(R)
Apr 15, 2009Video: Allergan, Inc. Marks 20 Years Since the First Approved Indications by the U.S. Food and Drug Administration for BOTOX(R) (Botulinum Toxin Type A)
Apr 3, 2009 Mar 27, 2009Video: Allergan Announces the LATISSE(TM) Wishes Campaign, Committing $1 Million to The Make-A-Wish Foundation(R)
Feb 4, 2009Allergan Reports Fourth Quarter 2008 Operating Results and Announces Restructuring
Jan 12, 2009| Showing 1-20 of 245 |
| Page: 1 2 3 ... 13 |
| Next 20 |